FibreSonic

FibreSonic

Matol's Dietary Fiber Supplement

Kert and Marilynn Goode, Independent Distributors Matol Botanical International, Ltd.
 

Year-long clinical study reveals wonderful results using Matol's fiber supplement Fibresonic -- Fibresonic® more effective than "Metamucil"®

Dr. Tapan K. Basu, Professor, Department of Agricultural, Food and Nutritional Science at the University of Alberta, recently completed Phase 1 (Clinical Study) of a two part Dietary Fiber Study. The following is a brief synopsis:

INTRODUCTION

Dietary fiber can be divided into two main categories -- water-soluble and water insoluble. Inadequate fiber intake has been linked to a variety of diseases, including bowel disorders, diabetes and cardiovascular disease.  Only a few commercially available fiber supplements contain both soluble and insoluble fiber.  This study was undertaken to compare the potential health benefits of Fibresonic (both types of fiber) with that of Psyllium, a hydrophilic mucilloid consisting of only soluble fiber (Metamucil).

CLINICAL STUDY: PHASE I

A.  PROCEDURES
A total of 23 subjects were recruited, all of which were over the age of 50. Focus was placed on subjects who, to some degree had a problem with constipation and an above average serum cholesterol level.  Subjects were given the two fiber supplements (Fibresonic and Metamucil), each for periods of approximately 30 days in random order.  The two periods of fiber feeding were separated by 28 days without fiber supplement (washout period). The subjects were instructed to eat their regular diet during the entire experimental period.
B.  RESULTS
1.  Colonic Function
The study revealed that the daily stool volume increased by Fibresonic supplementation in 4 out of 5 subjects (80%), while the Metamucil supplementation resulted in an increased stool volume in 3 out of 6 subjects (50%). The study also indicated that 4 out of 5 subjects who had an increased stool volume due to Fibresonic intake, experienced a decreased bowel transit time. The transit time was decreased in 3 out of 6 subjects taking Metamucil as a fiber supplement.
2.  Hypocholesterolemic Action
Twelve subjects were recruited for this study. Neither the Fibresonic nor the Metamucil had any effect on the plasma total cholesterol, LDL-cholesterol or triglycerides. However, Fibresonic resulted in an elevation of the HDL-cholesterol level (15%).

CONCLUSIONS

A. Colon Function
To a select group of subjects (50+), daily supplementation with one packet of Fibresonic containing 11 g of soluble and insoluble fiber for 30 days revealed an appreciable increase in stool volume and a decreased transit time. These results clearly indicate that Fibresonic could be used for an effective alleviation from constipation. In this respect, Fibresonic is more effective than Metamucil.
B. Cholesterol-lowering Action
Neither Fibresonic nor Metamucil had a positive effect on the plasma levels of total cholesterol, LDL-cholesterol and triglycerides. However, HDL-cholesterol (a protective factor against coronary heart disease, CHD) was significantly increased by Fibresonic supplementation for 30 days.

*Metamucil® is made by G.D. Searle & Co. Searle does not make or license Fibresonic®.

HOME |  PRODUCT LIST |  HOW TO ORDER |  WHAT'S NEW
BUSINESS OPPORTUNITY |  INTRODUCTION TO MLM

reviewed: February 18, 2007
Kert and Marilynn Goode
P.O. Box 1204
Bertram, Texas 78605
Tel: (512) 355-2374 Email: kgoode@goode-health.com